Abstract:Background/Aims: MicroRNAs play regulatory role in cardiovascular disease. MicroRNA-223 (miR-223) was found to be expressed abundantly in myocardium. TNNI3K, a novel cardiac troponin I (cTnI)-interacting and cardiac hypertrophy related kinase, is computationally predicted as a potential target of miR-223. This study was designed to investigate the cellular and molecular effects of miR-223 on cardiomyoctye hypertrophy, focusing on the role of TNNI3K. Methods: Neonatal rat cardiomyocytes (CMs) were cultured, and CMs hypertrophy was induced by endothelin-1 (ET-1). in vivo cardiac hypertrophy was induced by transverse aorta constriction (TAC) in rats. Expression of miR-223 in CMs and myocardium was detected by real-time PCR (RT-PCR). MiR-223 and TNNI3K were overexpressed in CMs via chemically modified sense RNA (miR-223 mimic) transfection or recombinant adenovirus infection, respectively. Cell size was measured by surface area calculation using fluorescence microscopy after anti-a-actinin staining. Expression of hypertrophy-related genes was detected by RT-PCR. The protein expression of TNNI3K and cTnI was determined by Western blots. Luciferase assay was employed to confirm the direct binding of miR-223 to the 3'UTR of TNNI3K mRNA. Intracellular calcium was measured by sensitive fluorescent indicator (Furo-2). Video-based edge detection system was employed to measure cardiomyocyte contractility. Results: MiR-223 was downregulated in ET-1 induced hypertrophic CMs and in hypertrophic myocardium compared with respective controls. MiR-223 overexpression in CMs alleviated ET-1 induced hypertrophy, evidenced by smaller cell surface area and downregulated ANP, alpha-actinin, Myh6 and Myh7 expression. Luciferase reporter gene assay showed that TNNI3K serves as a direct target gene of miR-223. In miR-223-overexpressed CMs, the protein expression of TNNI3K was significantly downregulated. MiR-223 overexpression also rescued the upregulated TNNI3K expression in hypertrophic CMs. Furthermore, cTnI phosphorylation was downregulated post miR-223 overexpression. Ad.rTNNI3K increased intracellular Ca2+ concentrations and cell shortening in CMs, while miR-223 overexpression significantly rescued these hypertrophic effects. Conclusion: By direct targeting TNNI3K, miR-223 could suppress CMs hypertrophy via downregulating cTnI phosphorylation, reducing intracellular Ca2+ and contractility of CMs. miR-223/TNNI3K axis may thus be major players of CMs hypertrophy. Copyright (C) 2015 S. Karger AG, Basel

Mir-218 Involvement in Cardiomyocyte Hypertrophy is Likely Through Targeting Rest

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Mir-96 Inhibits Cardiac Hypertrophy by Targeting Growth Factor Receptor-Bound 2.

Myocyte-specific Enhancer Factor 2C: a Novel Target Gene of Mir-214-3p in Suppressing Angiotensin II-induced Cardiomyocyte Hypertrophy.

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

Mir-139-5p Inhibits Isoproterenol-Induced Cardiac Hypertrophy by Targetting C-Jun

Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats

Inhibition of Mir-146B-5p Alleviates Isoprenaline-Induced Cardiac Hypertrophy Via Regulating DFCP1.

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a

Micrornas Are Dynamically Regulated in Hypertrophic Hearts, and Mir-199a is Essential for the Maintenance of Cell Size in Cardiomyocytes

Mir-34A Modulates Angiotensin II-induced Myocardial Hypertrophy by Direct Inhibition of ATG9A Expression and Autophagic Activity.

mir15a/mir16‐1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy

Mir-19B Controls Cardiac Fibroblast Proliferation and Migration.

CDK6 Mediates the Effect of Attenuation of Mir-1 on Provoking Cardiomyocyte Hypertrophy

MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.

Cardiomyocyte Overexpression of Mir-27B Induces Cardiac Hypertrophy and Dysfunction in Mice.

Overexpression of Microrna-99a Attenuates Cardiac Hypertrophy

MicroRNA-34c-5p Provokes Isoprenaline-Induced Cardiac Hypertrophy by Modulating Autophagy Via Targeting ATG4B

Microrna-327 Regulates Cardiac Hypertrophy And Fibrosis Induced By Pressure Overload

Mir-421-mediated Suppression of FGF13 As a Novel Mechanism Ameliorates Cardiac Hypertrophy by Inhibiting Endoplasmic Reticulum Stress.